Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > So, biobutthole

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Mar 12, 2022 5:40pm

170 Views

Post# 34509415

RE:RE:RE:So, biobutthole

Jimmy, not anybody's job to cover anything. Sirona is the only place to go for the answers here at the end of the day.

Its simple for me. The company has at least four potentially lucrative pipelines in play, of which two look to be most developed from a deal time perspective. Give us either treatment for animals or a top10 real credible deal and that is all that matters for us to be in orbit 9.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing